Systolic Blood Pressure Variability Independently Predicts CV Events and Death in Diabetes - The Cardiology Advisor (registration)

Systolic Blood Pressure Variability Independently Predicts CV Events and Death in Diabetes The Cardiology Advisor (registration) Previously, the results of the ADVANCE clinical trial (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation; ClinicalTrials.gov identifier: NCT00145925) identified VVV in SBP as a risk factor for ...